Xiamen Amoytop Biotech Co., Ltd.
688278.SSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
394
Cost of Revenue
26
Gross Profit
369
Gross Margin
93.5%
Operating Income
136
Operating Margin
34.5%
Net Income
116
Net Margin
29.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
139
EBITDA Margin
35.1%
2023
12/31/2023
Revenue
294
Cost of Revenue
20
Gross Profit
274
Gross Margin
93.3%
Operating Income
95
Operating Margin
32.4%
Net Income
78
Net Margin
26.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
100
EBITDA Margin
34.0%
2022
12/31/2022
Revenue
214
Cost of Revenue
24
Gross Profit
190
Gross Margin
88.8%
Operating Income
57
Operating Margin
26.7%
Net Income
40
Net Margin
18.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
56
EBITDA Margin
26.4%
2021
12/31/2021
Revenue
159
Cost of Revenue
18
Gross Profit
141
Gross Margin
88.8%
Operating Income
35
Operating Margin
22.0%
Net Income
25
Net Margin
16.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
36
EBITDA Margin
23.0%
2020
12/31/2020
Revenue
111
Cost of Revenue
12
Gross Profit
99
Gross Margin
89.2%
Operating Income
22
Operating Margin
19.9%
Net Income
16
Net Margin
14.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
23
EBITDA Margin
20.8%